Literature DB >> 13457525

Use of a thiophosphinyl quaternary compound (217-MI) in treatment of glaucoma.

I H LEOPOLD, P GOLD, D GOLD.   

Abstract

Entities:  

Keywords:  GLAUCOMA/therapy; PARASYMPATHOMIMETICS/therapeutic use

Mesh：

Substances：

Year:  1957        PMID： 13457525     DOI： 10.1001/archopht.1957.00940010375007

Source DB:  PubMed          Journal:  AMA Arch Ophthalmol        ISSN： 0096-6339


× No keyword cloud information.
  6 in total

1.  CLINICAL OBSERVATIONS ON THE USE OF PHOSPHOLINE IODIDE IN GLAUCOMA.

Authors:  J ROMANO; H JACKSON
Journal:  Br J Ophthalmol       Date:  1964-09       Impact factor: 4.638

2.  Observations on the use of phospholine iodide in the treatment of glaucoma.

Authors:  L A YOUNG
Journal:  J Natl Med Assoc       Date:  1963-01       Impact factor: 1.798

3.  Reduction in plasma cholinesterase levels after prolonged administration of echothiophate iodide eyedrops.

Authors:  T E Eilderton; O Farmati; E K Zsigmond
Journal:  Can Anaesth Soc J       Date:  1968-05

4.  Angle-closure glaucoma precipitated by the use of phospholine iodide for esotropia in a child.

Authors:  D E Jones; D M Watson
Journal:  Br J Ophthalmol       Date:  1967-11       Impact factor: 4.638

5.  PHOSPHOLINE IODIDE (217M1) (ECOTHIOPHATE IODIDE) IN THE TREATMENT OF GLAUCOMA.

Authors:  J P LLOYD
Journal:  Br J Ophthalmol       Date:  1963-08       Impact factor: 4.638

6.  Mechanism of the antagonism by pralidoxime and 1,1-trimethylenebis(4-hydroxyiminomethylpyridinium) of the action of echothiphate on the intestine.

Authors:  R A LEHMAN
Journal:  Br J Pharmacol Chemother       Date:  1962-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.